Skip to Content
Merck
CN

235296

2-(Trifluoromethyl)phenylacetic acid

98%

Synonym(s):

(α,α,α-Trifluoro-o-tolyl)acetic acid

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
CF3C6H4CH2CO2H
CAS Number:
Molecular Weight:
204.15
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
221-240-4
MDL number:
Assay:
98%
Form:
solid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

2-(Trifluoromethyl)phenylacetic acid, 98%

InChI key

TYOCDHCKTWANIR-UHFFFAOYSA-N

InChI

1S/C9H7F3O2/c10-9(11,12)7-4-2-1-3-6(7)5-8(13)14/h1-4H,5H2,(H,13,14)

SMILES string

OC(=O)Cc1ccccc1C(F)(F)F

assay

98%

form

solid

mp

100-102 °C (lit.)

functional group

carboxylic acid
fluoro

Quality Level

Application

2-(Trifluoromethyl)phenylacetic acid has been used in the synthesis of potential antithrombotics and lipoxygenase inhibitors.

pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

E S Lazer et al.
Journal of medicinal chemistry, 33(7), 1892-1898 (1990-07-01)
A series of 2,6-disubstituted 4-(2-arylethenyl)phenols with potent human neutrophil 5-lipoxygenase (5-LO) inhibiting activity (IC50S in the 10(-7) M range) and weaker human platelet cyclooxygenase (CO) inhibiting activity (IC50S in the 10(-6) M range) is described. This series evolved from the
P L Barker et al.
Journal of medicinal chemistry, 35(11), 2040-2048 (1992-05-29)
Stimulation of platelets activates GPIIbIIIa, the heterodimeric integrin receptor, to bind fibrinogen (Fg), which results in platelet aggregation. GPIIbIIIa/Fg binding inhibitors are potentially suitable for acute use during and after thrombolytic therapy as antithrombotic agents. Incorporation of the tripeptide sequence

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service